G2GBIO Inc
456160
Company Profile
Business description
G2GBIO Inc is a Biotechnology company. The company manages Drug Delivery System platform company. The company possesses microsphere source technology (InnoLAMP) for the development of sustained-release pharmaceuticals, and development a demand for extended-half-life drugs, as well as world-class mass production processes and facilities.
Contact
21 Medical Complex-gil
Osong-eup
Heungdeok-gu
Chungcheongbuk-do
Cheongju-si
KORT: +82 432706000
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
Employees
48
Stocks News & Analysis
stocks
Meta earnings: Strong end to 2025 as AI monetization begins to show
Investors please with latest results.
stocks
Why doesn’t the market like the earnings from this US tech giant?
Good quarter with AI demand ramping.
stocks
Our Tesla fair value increases meaningfully
Progress on Robotaxi and Optimus shows real world AI growth.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,236.90 | 6.40 | -0.07% |
| CAC 40 | 8,071.36 | 4.68 | 0.06% |
| DAX 40 | 24,309.46 | 513.33 | -2.07% |
| Dow JONES (US) | 48,953.60 | 62.00 | -0.13% |
| FTSE 100 | 10,171.76 | 17.33 | 0.17% |
| HKSE | 27,968.09 | 141.18 | 0.51% |
| NASDAQ | 23,434.98 | 422.47 | -1.77% |
| Nikkei 225 | 53,375.60 | 16.89 | 0.03% |
| NZX 50 Index | 13,348.61 | 64.26 | -0.48% |
| S&P 500 | 6,918.45 | 59.58 | -0.85% |
| S&P/ASX 200 | 8,927.50 | 4.30 | 0.05% |
| SSE Composite Index | 4,157.98 | 6.75 | 0.16% |